EUCTR2004-003784-68-SE进行中（未招募）不适用
Subcutanoeus Delivery of Filgrastim (rG-CSF) for the Promotion of Collateral Growth in Patients with Coroanry Artery Disease (FILCAD) - FILCAD
niversity Hospital Bern0 个研究点目标入组 60 人开始时间: 2004年11月10日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •1.Age > 18 years old
- •2.1- to 3-vessel coronary artery disease (CAD)
- •3.Stable angina pectoris
- •4.At least 1 stenotic lesion suitable for PCI
- •5.No Q-wave myocardial infarction in the area undergoing CFI measurement
- •6.Written informed consent to participate in the study
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •1.Patients admitted as emergencies
- •2.Acute myocardial infarction
- •3.Unstable CAD
- •4.CAD treated best by CABG
- •5.Severe valve disease
- •6.Patients with overt neoplastic disease
- •7.Patients with diabetic retinopathy
- •8.Overt liver disease
- •9.Renal insufficiency (creatinine level > 200 µmol/L) or other overt renal
- •10.Pre-menopausal women
研究者
相似试验
已完成
不适用
Filgrastim for the Promotion of Collateral Growth in Patients With CADCoronary Artery DiseaseNCT00596479Insel Gruppe AG, University Hospital Bern50
招募中
Unknown
G-Lasta (pegfilgrastim) Subcutaneous Injection 3.6 mg General use-results survey (all-case survey) -Mobilization and collection of Hematopoietic Stem Cells into Peripheral Blood for Allogeneic Blood Stem Cell TransplantationAll donors who have received pegfilgrastim for the first time after the date of approval of the indication "Mobilization of Hematopoietic Stem Cells into Peripheral Blood for Allogeneic Blood Stem Cell Transplantation"JPRN-UMIN000052251Other350
招募中
4 期
Subcutaneous Frusemide in patients with heart failureDecompensated Heart FailureCardiovascular - Coronary heart diseaseCardiovascular - Other cardiovascular diseasesACTRN12612000477820Auckland City Hospital20
已完成
1 期
Comparison of Filgrastim and Filgrastim SD/01in Boosting White Cell Counts After Intensive ChemotherapyHigh-risk SarcomaSynovial SarcomaRhabdomyosarcomaMPNSTEwing's SarcomaNCT00004853National Cancer Institute (NCI)34
招募中
不适用
Retreatment with subcutaneous Infliximab in patients with refractory Crohn’s diseaseK50Crohn disease [regional enteritis]DRKS00030670niversitätsklinikum Freiburg30